Jamie Pearson has been a highly respected leader in the cannabis industry for over a decade. Her “in the trenches” operational success and deep, global relationships led her to be coined “Wonder Woman” in the 2023 Women of Influence issue of Cannabis Now Magazine. Fluent in German, Jamie spent decades in the global real estate investment and finance world on three continents. She currently sits on the advisory boards of Dope Drinks, Marley One, Cellotex Dev Ltd, Global Cannabis Network Collective (GCNC), Lift & Co, and Alpen Group AG.
Jamie founded and leads The New Holland Group, a global consulting firm serving clients with international business development & strategy, seed to sale operations, branding & marketing, effective capital raising, executive coaching, cross border IP licensing, celebrity partnerships, buy & sell side M&A, and financial turnarounds. Client referrals have been New Holland Group’s only source of business and business is booming!
Before New Holland Group, Jamie spent seven years, including three as the President & CEO, of Bhang Inc. [CSE:BHNG] one of the world’s most-awarded and recognized cannabis edible brands, famous for its infused chocolate bars. She led the company’s diverse executive team, managed the “expansion through licensing” plan, ran the capital markets division, and was the face of the brand – catapulting Bhang from a California favorite to a multi-state and multi-national phenomenon. When Jamie exited Bhang the brand had been distributed in 7 US states and 10 countries through licensing deals with the likes of Trulieve, [CSE:TRUL], Indiva [TSX:NDVA] and Origin House [CSE:OH] (now Cresco). Jamie served four years as the Vice Chairman of Bhang’s Board and served on the Board’s audit committee.
Jamie is a popular speaker with competence in the areas of global expansion, ESG, IP & brand licensing, real estate acquisition, creative deal structuring, celebrity partnerships, business development, and leadership. Jamie can be reached at jamie@new-holland.group.

Robert Jappie is a Partner at Fieldfisher LLP. He specialises in Life Sciences Regulation for the UK and Europe, providing advice and representation to a range of nascent industries in the Life Sciences sector. Robert advises businesses operating in highly regulated industries across the Life Sciences sector, with a particular focus on Healthcare, Plant-Based Therapies, Vaping, Food/Agri-Tech and Regulated Substances.

Robert is the leading legal authority on Cannabis in the UK. In addition to providing expert advice on all the day-to-day regulatory issues that Medical Cannabis companies face, he has advised on several Cannabis-related transactions in the UK, including Acquisitions, ECM, and POCA compliance matters.

Michael Sassano is a highly influential executive who drives a unique dual strategy in the pharmaceutical cannabis space. As Founder and Chairman of Somaí Pharmaceuticals through Green Rush Partners and Interim CEO of Somaí, he directs a leading, globally-focused EU-GMP vertically integrated Multi-Country Operator (MCO). Somaí maintains market leadership with the largest and most advanced EU-GMP-certified cannabinoid extract portfolio and high-end craft indoor flowers, ensuring the broadest global distribution reach. This leadership extends to the premium consumer segment, where Somaí strategically manufactures and serves as the global distributor for renowned brands like Cookies, AirPro, Sherbinskis, and Jack Herer.

Ricardo is a partner in the Regulatory and Compliance Group at leading UK law firm Irwin Mitchell. He advises UK and international businesses on compliance, investigations and market access, with a specialism in the medicinal cannabis sector as well as the CBD wellness markets.

His expertise centers on designing compliant routes to market, navigating regulator scrutiny, and managing risk across the UK, EU and multi‑jurisdictional projects.

Ricardo regularly advises global cannabis companies on the legality and labelling of medical cannabis products as well as advertising of medical cannabis business, as well as Home Office licensing for controlled drugs and cultivation. He has also advised on matters pertaining too‑cigarettes/e‑liquids, cosmetics, foods and supplements.

Due to the nature of the sector and the legal nuances involved, Ricardo often works closely with other legal departments such as corporate and commercial, employment, dispute resolution and intellectual property/image rights to ensure his clients benefit from a full suite of legal services specifically tailored to their immediate business needs and future objectives.

His public commentary includes articles in The Times on ‘Medical Cannabis is Legal if you can get it’, disposable‑vape policy, and the legitimate use cases for crypto, and he is a regular speaker and moderator at cannabis industry conferences in the UK and abroad. Ricardo also sits on the executive committee of the UK’s Cannabis Industry Council.

Max Narr is a Non-Executive Director of Organigram Global. Previously, as Chief Strategy & Investment Officer of Sanity Group, he led the company’s strategy, M&A and financing activities. As external advisor, he later managed Sanity Group’s side of the acquisition by Organigram, completed in 2026 and now represents the former Sanity Group shareholders on the Organigram board.
Max co-founded Endosane Pharmaceuticals, where he has served as Managing Director since 2021, developing cannabinoid-based finished medicines for psychiatric and neuropsychiatric conditions.
Before joining Sanity Group in 2020, he led the IPO of IBU-tec advanced materials AG as Head of Investor Relations and subsequently its acquisition of BNT Chemicals, where he served as Commercial Director. Earlier this year, he rejoined IBU-tec AG as member of its supervisory board.
Max‘ primary focus today is the management of the quant-based, AI-native venture capital Fund Blue Forest, which he co-founded in 2025.

Jon Robson is the Founder and CEO of Mamedica, the UK’s leading digital platform for medical cannabis. Under his leadership, Mamedica has scaled rapidly to serve thousands of patients nationwide, delivering clinically-led access to cannabis-based medicines. Mamedica was recently named one of Entrepreneur Magazine’s Top 100 London Startups, recognising its innovation, growth and impact on patient care. A vocal advocate for policy reform, Jon has contributed to leading reports including the London Drugs Commission’s “Cannabis Conundrum” and frequently engages with regulators, media and investors to drive the conversation forward.

Kraig G. Fox is a seasoned advisor, investor and operator in the media industry. Over a 30 year + career, Mr. Fox has been a founding member of some of the worlds leading media and entertainment companies and properties.
Mr. Fox began his career working with Robert FX Sillerman in the consolidation of the United States radio industry in the early 1990’s. After an aggressive acquisition strategy, via multiple controlled public companies, those stations were ultimately sold off to form the foundation for what today is iHeart Media.
Following the sale of the radio group, Mr. Fox was part of the founding team of publicly traded SFX Entertainment (now Live Nation) where he was Chief Development Officer from 1995 until 2000 overseeing the global consolidation of the live entertainment industry into the world’s largest owner and operator of live entertainment promoters and producers.
Following the sale of Live Nation to Clear Channel Communications, Mr. Fox was a founder and Chief Operating Officer of Core Media (previously CKX, Inc.) where he ultimately oversaw all operations of this publicly traded company, including Core Media’s interests in the estate of Elvis Presley and the intellectual property rights of Muhammad Ali, as well as its wholly owned subsidiary, 19 Entertainment, which included overseeing American Idol (including television, records, live tours, artist management and sponsorships) and So You Think You Can Dance. Core Media was ultimately sold to Apollo Global Management in a “go private” transaction.
Following the sale, Mr. Fox became a Senior Managing Director of Eldridge Industries (a successor entity to certain media assets controlled by Guggenheim Partners) where he focused on Eldridge’s overall strategy in the media and entertainment spaces, as well as the management of its media and entertainment investments, which included dick clark productions, Billboard Magazine and the Hollywood Reporter.
Mr. Fox has also been an investor, operator and advisor in the regulated cannabis industry going back to 2014. He a founder and Chief Executive Officer of Reklaim Credit Solutions, Inc. a purposed built commercial credit rating and reporting agency for any business extending trade credit in the state regulated cannabis industries.
Mr. Fox is a graduate of Syracuse’s University’s SI Newhouse School of Public Communications where he was named part of the 50 Forward, acknowledging the accomplishments of 50 Newhouse Alumni in celebration of the schools 50th anniversary. Mr. Fox also holds a JD from Hofstra University’s Maurice A. Dean School of Law and is admitted to practice law in the NY’s Second District.

Chief Inspiration Officer – Sullivan Adventures LLC
Partner: New Holland Group
Keynote Speaker – Advisor – Investor

Jeanne M. Sullivan is a passionate about delivering ideas – information – and inspiration to entrepreneurs – Sullivan has been early to various sectors – investing in tech infrastructure, the internet wave, cloud-based computing, data aggregation and early in the cannabis sector. She is thrilled to leverage years in this industry and support entrepreneurs seeking European-based cannabis opportunities.
She co-founded an early-stage cannabis fund and is a frequent speaker on the conference circuit. Sullivan has been part of the Arcview Group and Arcview Ventures since 2015.

Jeanne co-founded StarVest Partners, a venture capital firm in NYC raising $400 million to invest in tech-enabled business services companies. Prior to her venture experience with StarVest and Olivetti Ventures, Jeanne gained her operating experience with AT&T and Bell Labs while serving in product and industry marketing roles.

Ms. Sullivan has served on the board of multiple technology and cannabis companies and has extensive experience creating “go to market” plans for growth and expansion stage companies. Her expertise also includes strategy, an understanding of the tech and cannabis landscape and industry trends. Sullivan lives in New York City.

Connect: Linkedin.com/in/jeannemsullivan

Kim Sanchez Rael is CEO and Co-Founder of Azuca, an applied biotechnology company using plant-based food science to precisely control how ingestible cannabinoids are delivered, absorbed, and experienced. Under her leadership, Azuca has become the foundational delivery platform for ingestible cannabinoids, with formulations infusing more than 700 million servings across medical and adult-use markets.

Azuca addresses one of the category’s most persistent challenges: achieving reliable dosing, predictable onset, and consistent bioavailability at commercial scale. Kim has built the company by pairing clinically informed formulation science with manufacturing systems that are repeatable, regulator-ready, and practical to deploy across diverse production environments.

She is a start-up veteran, operating executive, and long-time investor with experience spanning venture capital, early-stage company building, and Fortune 50 leadership. Kim has deep experience operating in regulated environments and served as Chair of the Board of Regents of the University of New Mexico. She holds a bachelor’s degree from Harvard University and an MBA from Stanford University and was named to the Inc. “Female Founders 500” and Forbes “50 over 50” lists in 2025.

Kraig G. Fox is a seasoned advisor, investor and operator in the media industry. Over a 30 year + career, Mr. Fox has been a founding member of some of the worlds leading media and entertainment companies and properties.
Mr. Fox began his career working with Robert FX Sillerman in the consolidation of the United States radio industry in the early 1990’s. After an aggressive acquisition strategy, via multiple controlled public companies, those stations were ultimately sold off to form the foundation for what today is iHeart Media.
Following the sale of the radio group, Mr. Fox was part of the founding team of publicly traded SFX Entertainment (now Live Nation) where he was Chief Development Officer from 1995 until 2000 overseeing the global consolidation of the live entertainment industry into the world’s largest owner and operator of live entertainment promoters and producers.
Following the sale of Live Nation to Clear Channel Communications, Mr. Fox was a founder and Chief Operating Officer of Core Media (previously CKX, Inc.) where he ultimately oversaw all operations of this publicly traded company, including Core Media’s interests in the estate of Elvis Presley and the intellectual property rights of Muhammad Ali, as well as its wholly owned subsidiary, 19 Entertainment, which included overseeing American Idol (including television, records, live tours, artist management and sponsorships) and So You Think You Can Dance. Core Media was ultimately sold to Apollo Global Management in a “go private” transaction.
Following the sale, Mr. Fox became a Senior Managing Director of Eldridge Industries (a successor entity to certain media assets controlled by Guggenheim Partners) where he focused on Eldridge’s overall strategy in the media and entertainment spaces, as well as the management of its media and entertainment investments, which included dick clark productions, Billboard Magazine and the Hollywood Reporter.
Mr. Fox has also been an investor, operator and advisor in the regulated cannabis industry going back to 2014. He a founder and Chief Executive Officer of Reklaim Credit Solutions, Inc. a purposed built commercial credit rating and reporting agency for any business extending trade credit in the state regulated cannabis industries.
Mr. Fox is a graduate of Syracuse’s University’s SI Newhouse School of Public Communications where he was named part of the 50 Forward, acknowledging the accomplishments of 50 Newhouse Alumni in celebration of the schools 50th anniversary. Mr. Fox also holds a JD from Hofstra University’s Maurice A. Dean School of Law and is admitted to practice law in the NY’s Second District.

Daniel Cook is a seasoned growth company leader with a track record of scaling businesses from early-stage to over $250 Million in enterprise value. He specializes in building high impact companies in emerging markets and
breakthrough categories.

Daniel is currently CEO of True Companies (Trueco), a specialized flavor house with deep domain expertise in
terpenes—the molecular building blocks behind more than $8 Billion in annual consumer product formulations across cannabis, beer, and CPG. Under his leadership, Trueco has grown EBITDA 10X and sales 4X in less than five years. [2020-Present]

Prior to Trueco, Daniel helped build Endeavor’s Global Entrepreneur Support Program. This program worked with the top high growth entrepreneurs in emerging markets across a variety of industries to help them refine their strategy, raise capital, forge partnerships and recruit talent. During his tenure, Endeavor helped to catalyze over $1.5 Billion in exits for founders in emerging markets. Today, Endeavor backs over 37 unicorns outside of China, making it the most active investor in billion-dollar scaleups in those regions. [1999-2002]

Daniel spent over six years in South America leading growth initiatives in the wine industry—first as a Fulbright Scholar in Chile, and later running commercial operations for Moët Hennessy’s Argentina portfolio, including Terrazas de los Andes (>200,000 cases sold/year) and Cheval des Andes, a joint venture with storied Premier Grand Cru Classe A – Chateau Cheval Blanc, both LVMH “Rising Star Brands.” [2004-2008]

Daniel has served as a founder, advisor, and board member to high-growth companies across cannabis, clean energy, regenerative agriculture, and natural products. He built Keen-Wah(+) Foods® a portfolio of consumer natural foods products that have been tested and approved by an avid community of 250,000 healthy living supporters and rolled out to thousands of points of sale (acq. by Nestlé Americas as a part of a multi-brand rollup). He also served as an Entrepreneur-in-Residence for Califia Farms, a pioneer in the plant-based dairy product category (almond) and innovator in plant-based milks, creamers, juices, and dairy-free probiotic yogurts, where he and helped bring to market natural products generating hundreds of millions in revenue. [2008-2020]

Daniel holds an MBA from Harvard Business School, where he received the Social Enterprise Scholarship for his work on venture capital in underserved communities, and was nominated for the Dean’s Award after leading the first private clean energy installation at Harvard. [2002-2004]

He earned a BA in Literature from Fairfield University, was awarded a Fulbright to Chile, and served as an Eisenhower Ambassador to the UK, Sweden, Finland, and Russia. [1992-1996].

Chief Inspiration Officer – Sullivan Adventures LLC
Partner: New Holland Group
Keynote Speaker – Advisor – Investor

Jeanne M. Sullivan is a passionate about delivering ideas – information – and inspiration to entrepreneurs – Sullivan has been early to various sectors – investing in tech infrastructure, the internet wave, cloud-based computing, data aggregation and early in the cannabis sector. She is thrilled to leverage years in this industry and support entrepreneurs seeking European-based cannabis opportunities.
She co-founded an early-stage cannabis fund and is a frequent speaker on the conference circuit. Sullivan has been part of the Arcview Group and Arcview Ventures since 2015.

Jeanne co-founded StarVest Partners, a venture capital firm in NYC raising $400 million to invest in tech-enabled business services companies. Prior to her venture experience with StarVest and Olivetti Ventures, Jeanne gained her operating experience with AT&T and Bell Labs while serving in product and industry marketing roles.

Ms. Sullivan has served on the board of multiple technology and cannabis companies and has extensive experience creating “go to market” plans for growth and expansion stage companies. Her expertise also includes strategy, an understanding of the tech and cannabis landscape and industry trends. Sullivan lives in New York City.

Connect: Linkedin.com/in/jeannemsullivan

Kai is characterized by his outstanding expertise and diverse practice in the cannabis industry. With a broad range of expertise in cannabis and business law, he provides comprehensive legal support to companies and individuals.
From contract drafting and company formation to day-to-day legal support, he assists cannabis companies with customized solutions in all legal matters, including white collar criminal law where necessary.
Kai is also the author of the blog canna-biz.legal, where he positions himself as an expert in the thriving cannabis business. Canna-biz.legal not only provides insights into the legal status of cannabis in Germany and Europe today, but also current developments and offers resources for businesses and interested parties.
His work spans all aspects of the cannabis industry, from advising companies on cultivation licenses and production regulations to assisting with regulatory issues in product development. His deep understanding of the complex legal framework in this sector makes him a sought-after contact.
Kai and his law firm KFN+ advise large CBD and medical cannabis companies, as well as companies and associations interested in the emerging recreational cannabis market. He is also advisor to the European Industrial Hemp Association (EIHA), which has submitted a joint application to the EU Commission for authorization as a novel food for various CBD products.
With an international perspective, Kai operates not only nationally, but also across borders. His network in the industry enables him to support companies in their global activities and adapt to the challenges of an ever-changing legal landscape.
Kai regularly speaks at international cannabis conferences on topics related to the German and European legal framework for cannabis, and publishes articles at Krautinvest, BusinessCann and in law journals.
Born in Löhne/Westf. in 1972, studied law at the Universities of Marburg, Adelaide (Australia), Cologne, legal assistant at the press center of the German Bundestag (2000-2002), worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Berlin Office for the Protection of the Constitution and the Hong Kong Consulate General.

Dr. Jan Rasmus Ludwig is an experienced solicitor who specialises in providing comprehensive advice to clients on pharmaceutical advertising and all aspects of intellectual property law. His areas of expertise include health technology and life sciences, with a focus on medical cannabis, regulatory issues and recreational cannabis. Dr. Ludwig has been admitted to the bar since 2007 and is a partner at BRP RENAUD. As a specialist lawyer for industrial property rights, copyright and media law, Jan’s practice concentrates primarily on IP litigation. He has been involved in landmark decisions before the Federal Court of Justice in copyright and design law. Additionally, Dr. Jan Rasmus Ludwig also advises national and international companies and investors in the fields of medical cannabis, medical devices and dietary supplements, and the entire product and business development cycle of the dynamically growing cannabis industry.

Torsten Greif is Member of the Board of Directors at Curaleaf Inc. and a German entrepreneur and business leader with a strong track record across multiple industries, including real estate, renewable energy, gaming, and medical cannabis.
He began his career in the insurance industry, gaining experience in sales, distribution, and product management, as well as working at Deloitte in Germany. Later he shifted toward entrepreneurship and investment, co-founding and building several companies.
In 2018, Mr. Greif co-founded Four 20 Pharma GmbH in Paderborn, Germany, and in 2021, he assumed joint operational leadership together with a co-founder, driving the company’s growth and stability. A year later, Curaleaf acquired a 55% stake in Four 20 Pharma, marking a major milestone in the European medical cannabis sector. Mr. Greif studied at the University of Paderborn and Northwood University (Michigan, USA), earning his B.B.A., and an MBA in Corporate Strategy & Economic Policy at the Maastricht School of Management in 2004.

Judith Heimbürger is an experienced lawyer specialising in advising clients in the life sciences sector.
She works with national and international companies as well as investors across pharmaceuticals, medicinal cannabis, medical devices, biotechnology and diagnostics, supporting them throughout the entire product and business development lifecycle.

Her clients particularly value her expertise in drafting and negotiating complex agreements, including cross-border supply and licensing arrangements (especially relating to patents and know-how), research and development agreements, collaboration and supply agreements, as well as contracts for clinical trials.

Judith also has significant experience advising on and leading cross-border M&A transactions, joint ventures and strategic partnerships in the life sciences sector. In addition, she advises on compliance matters, pharmaceutical advertising law, collaborations with physicians and pharmacists, and a wide range of regulatory issues relating in particular to medicinal cannabis, medicinal products and medical devices.

A further key focus of her practice is providing legal advice on medicinal cannabis as well as CBD products – ranging from regulatory matters and contract law advice to M&A transactions.

As Canopy Growth’s Chief Business Development & Corporate Affairs Officer, Christelle Gedeon oversees the company’s global Legal, M&A, Regulatory, and IT Compliance functions across North America, Europe, and Asia-Pacific.
A transformational executive and strategic counsellor, Christelle plays a central role in advancing Canopy Growth’s long-term strategy, including executing the company’s multiyear business transformation, restructuring over US$700 million in debt, and architecting Canopy USA — a first-of-its-kind structure enabling U.S. market participation while maintaining NASDAQ compliance.
Before joining Canopy, she served as Chief Legal Officer at The Metals Company, where she guided its deSPAC transaction and ESG governance framework, and as Chief Legal Officer at Aphria Inc., where she led major regulatory and transactional initiatives. Earlier in her career, she was a Partner at Fasken, advising clients in highly regulated sectors on complex regulatory, transactional, and governance matters.
Christelle holds a Ph.D. in Clinical Pharmacology and Toxicology from the University of Toronto and a dual law degree (LL.B./B.C.L.) from McGill University. She is dual barred in Ontario and Quebec, a registered trademark agent, and certified by Competent Boards with the GCB.D ESG governance designation.
Additionally, she has been named one of Canada’s Law Department Leaders of the Year, included in the Legal 500 GC Powerlist, and recognized as a Tomorrow’s Leader by the Canadian General Counsel Awards.